指南与共识消化系统肿瘤

泛亚洲改编版ESMO转移性胃癌管理临床实践指南:JSMO-ESMO倡议,获CSCO、KSMO、MOS、SSO及TOS认可

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS.
指南 / 共识 · Ann Oncol · 2019-01-01

该指南由ESMO与JSMO牵头,在2018年JSMO年会后就2016版ESMO胃癌指南进行泛亚洲改编,纳入亚洲转移性胃癌患者的种族差异。共识由日本、中国、韩国、马来西亚、新加坡及台湾的肿瘤学会专家投票形成,投票基于科学证据,独立于各地治疗实践与药物可及性。

要点

  • 指南为2016版ESMO胃癌指南的泛亚洲改编版,聚焦转移性胃癌的种族差异。
  • 共识由JSMO、CSCO、KSMO、MOS、SSO及TOS六个亚洲学会专家投票形成。
  • 投票基于科学证据,独立于各参与国的治疗实践与药物可及性及报销情况。

核心结论

  • 该指南代表日本、中国、韩国、马来西亚、新加坡及台湾的肿瘤学会专家对亚洲转移性胃癌治疗达成的共识意见。

研究设计与样本

  • ESMO与JSMO于2017年11月ESMO亚洲会议决定,在2018年JSMO年会后召开特别指南会议,对2016版ESMO胃癌指南进行泛亚洲改编。

主要发现

  • 投票基于科学证据,独立于各参与亚洲国家当前的治疗实践及药物可及性与报销情况。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The most recent version of the European Society for Medical Oncology (ESMO) Clinical Practice Guidelines for the diagnosis, treatment and follow-up of gastric cancer (GC) was published in 2016, and covered the management and treatment of local, locoregional, locally advanced and metastatic disease. At the ESMO Asia Meeting in November 2017 it was decided by both ESMO and The Japanese Society of Medical Oncology (JSMO) to convene a special guidelines meeting immediately after the JSMO Annual Meeting in 2018. The aim was to adapt the ESMO 2016 guidelines to take into account the ethnic differences associated with the treatment of metastatic GC in Asian patients. These guidelines represent the consensus opinions reached by experts in the treatment of patients with metastatic GC representing the oncological societies of Japan (JSMO), China (CSCO), Korea (KSMO), Malaysia (MOS), Singapore (SSO) and Taiwan (TOS). The voting was based on scientific evidence and was independent of both the current treatment practices and the drug availability and reimbursement situations in the individual participating Asian countries.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Muro K, Van Cutsem E, Narita Y, et al. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol. 2019. PMID: 30475956. doi:10.1093/annonc/mdy502

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。